This week on Contemporary OB/GYN®: Feb. 14 to Feb. 18
A look at what's coming to Contemporary OB/GYN this week
In Utero COVID-19 vaccine exposure not associated with adverse outcomes
The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.
S4E2: Contraceptive care considerations for incarcerated women
This episode of Pap Talk features Michael Krychman, MD and Gloria Bachmann, MD, MSc.
Coming soon
In this issue: February 2022
Take a look inside this issue of Contemporary OB/GYN®.
Coming soon
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
